Literature DB >> 6858791

Metal binding by pharmaceuticals. Part 3. Copper (II) and zinc (II) interactions with isoniazid.

A Cole, P M May, D R Williams.   

Abstract

Formation constants for copper(II) and zinc(II) complexes of isonicotinoylhydrazine (isoniazid) and guanosine-5'-monophosphate have been measured potentiometrically at 37 degrees C, I = 150 mmol dm-3 [NaCl]. These constants have been used in computer models to assess the extent of complex formation by the drug in vivo. The simulations indicate that the predominant complexes existing in blood plasma are ternary species formed with histidinate. However, at clinical levels of isoniazid, it seems unlikely that these complexes are physiologically significant. On the other hand, ternary complex formation with nucleosides may be involved in the binding of isoniazid to viral RNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6858791     DOI: 10.1007/bf01994289

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  34 in total

1.  Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid.

Authors:  F WINDER
Journal:  Am Rev Respir Dis       Date:  1960-01

2.  Mode of action of isoniazid.

Authors:  A ALBERT
Journal:  Nature       Date:  1956-03-17       Impact factor: 49.962

3.  [On isonicotinylhydrazide-copper complexes; metallic ions and biologic effects].

Authors:  S FALLAB; H ERLENMEYER
Journal:  Experientia       Date:  1952-08-15

4.  Oxidation of isonicotinic acid hydrazide by the peroxidase system. The formation of an excited product.

Authors:  K Zinner; C C Vidigal; N Durán; G Cilento
Journal:  Arch Biochem Biophys       Date:  1977-04-30       Impact factor: 4.013

5.  Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.

Authors:  S D Nelson; J R Mitchell; J A Timbrell; W R Snodgrass; G B Corcoran
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

6.  Interaction of metal ions with polynucleotides and related compounds. XIV. Nuclear magnetic resonance studies of the binding of copper(II) to adenine nucleotides.

Authors:  N A Berger; G L Eichhorn
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

7.  Lung carcinogenesis with 1-acetyl-2-isonicotinoylhydrazine, the major metabolite of isoniazid.

Authors:  B Toth; H Shimizu
Journal:  Eur J Cancer       Date:  1973-04       Impact factor: 9.162

8.  Sites and thermodynamic quantities associated with proton and metal ion interaction with ribonucleic acid, deoxyribonucleic acid, and their constituent bases, nucleosides, and nucleotides.

Authors:  R M Izatt; J J Christensen; J H Rytting
Journal:  Chem Rev       Date:  1971-10       Impact factor: 60.622

9.  An assessment of the possible association of isoniazid with human cancer deaths.

Authors:  J L Glassroth; M C White; D E Snider
Journal:  Am Rev Respir Dis       Date:  1977-12

10.  Enhancement by transition metals of unscheduled DNA synthesis induced by isoniazid and related hydrazines in cultured normal and xeroderma pigmentosum human cells.

Authors:  R F Whiting; L Wei; H G Stich
Journal:  Mutat Res       Date:  1979-10       Impact factor: 2.433

View more
  4 in total

1.  Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.

Authors:  Christopher I Zoumalan; Madhu Agarwal; Alfredo A Sadun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-23       Impact factor: 3.117

2.  Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds.

Authors:  H Al-Falahi; P M May; A M Roe; R A Slater; W J Trott; D R Williams
Journal:  Agents Actions       Date:  1984-01

3.  Metal ion-tetracycline interactions in biological fluids. Part 5. Formation of zinc complexes with tetracycline and some of its derivatives and assessment of their biological significance.

Authors:  M Brion; L Lambs; G Berthon
Journal:  Agents Actions       Date:  1985-12

4.  Metal binding by pharmaceuticals. Part 5. Interaction of Cd(II), Ni(II) and Pb(II) with the intracellular hydrolysis products of the anti-tumour agent ICRF 159 and its inactive homologue ICRF 192.

Authors:  P M May; M J Willes; D R Williams; A M Creighton
Journal:  Agents Actions       Date:  1984-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.